Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
Brent A. Neuschwander‐Tetri(Saint Louis University)
Cited by 1,084
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
|Hepatology|2003|2.1k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2018|593